Acceleron Pharma Inc - Company Profile

Powered by

All the sales intelligence you need on Acceleron Pharma Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Acceleron Pharma Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Acceleron Pharma Inc.

Back to companies

Acceleron Pharma Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Acceleron Pharma Inc, a subsidiary of Merck & Co Inc, operates within the pharmaceuticals and healthcare industry, specifically focusing on technology services. It specializes in biotechnology solutions and innovations. The company is headquartered in United States.

 Gain a 360-degree view of Acceleron Pharma Inc and make more informed decisions for your business Gain a 360-degree view of Acceleron Pharma Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address 128 Sidney St, 126 East Lincoln Avenue, Rahway, New Jersey, 07065
No of Employees 312
Industry Pharmaceuticals and Healthcare
Revenue (2020) $92.5M
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Acceleron Pharma Inc premium industry data and analytics

30+

Clinical Trials

Determine Acceleron Pharma Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

30+

Catalyst Calendar

Proactively evaluate Acceleron Pharma Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Pipeline Drugs

Identify which of Acceleron Pharma Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

Products and Services

Products
Commercial:
Reblozyl (luspatercept-aamt)- for anemia with beta-thalassemia and myelodysplastic syndromes patients.
Pipeline Product:
XYZ
XYZ
XYZ
Understand Acceleron Pharma Inc portfolio and identify potential areas for collaboration Understand Acceleron Pharma Inc portfolio and identify potential areas for collaboration Learn more
Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Acceleron Pharma Inc key executives to enhance your sales strategy Gain insight into Acceleron Pharma Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?